Registered Nurse in Gastonia, NC Accepting Medicare

165 Registered Nurse nurses found. Showing 161 - 165

Donna Marquardt, R.N. Registered Nurse - Community Health Medicare: Not Enrolled in Medicare Practice Location: 911 West Hudson Blvd., Gastonia, NC 28052 Phone: 704-853-5258

Mrs. Wanda Clary, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 991 W Hudson Blvd, Gastonia, NC 28052 Phone: 704-853-5000

Pamela Mcleod Barnette, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 991 W Hudson Blvd, Gastonia, NC 28052 Phone: 704-853-5000

Megan Graves, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 991 W Hudson Blvd, Gastonia, NC 28052 Phone: 704-853-5000

Gina Greene, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 991 W Hudson Blvd, Gastonia, NC 28052 Phone: 704-853-5000    Fax: 704-853-5188

News Archive

Viewpoints: Cancer's deadly toll in minority communities; GOP candidates need to go on offense against health law

Since the early 1970s, studies have shown that black Americans have a higher death rate from cancer than any other racial or ethnic group.

Scientists find way to apply pressure to make material expand

When you squeeze something, it gets smaller. Unless you're at Argonne National Laboratory. At that suburban Chicago laboratory, a group of scientists has seemingly defied the laws of physics and found a way to apply pressure to make a material expand instead of compress/contract.

SRI awarded DOE grant to expand MetaCyc database and enhance Pathway Tools software

SRI International, an independent nonprofit research and development organization, announced today it has been awarded a grant by the Department of Energy (DOE) to expand its MetaCyc database and enhance its Pathway Tools software. This project will give SRI's bioinformatics tools even greater utility in the emerging area of bioenergy, or renewable energy derived from biological sources.

Flamel Technologies initiates IFN-alpha-2b XL Phase 2a clinical trial for HCV

Flamel Technologies today announced the initiation of a Phase 2a clinical trial of Flamel's Interferon alpha-2b XL (IFN-alpha-2b XL), which is based on Flamel's Medusa® platform for controlled release of biologics. IFN-alpha-2b XL is being developed as a controlled release of unmodified interferon alpha-2b for the treatment of chronic hepatitis C virus (HCV).

Researchers finds further evidence for genetic contribution to autism

Some parents of children with autism evaluate facial expressions differently than the rest of us-and in a way that is strikingly similar to autistic patients themselves, according to new research by neuroscientist Ralph Adolphs of the California Institute of Technology and psychiatrist Joe Piven at the University of North Carolina at Chapel Hill.

Read more Medical News

› Verified 2 days ago

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9(current)